Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $35,403 - $44,013
146 Added 5.85%
2,643 $649,000
Q2 2022

Aug 10, 2022

SELL
$224.73 - $338.64 $358,893 - $540,808
-1,597 Reduced 39.01%
2,497 $618,000
Q1 2022

May 12, 2022

BUY
$277.25 - $366.29 $58,222 - $76,920
210 Added 5.41%
4,094 $1.36 Million
Q4 2021

Feb 10, 2022

SELL
$300.63 - $371.35 $5,110 - $6,312
-17 Reduced 0.44%
3,884 $1.4 Million
Q3 2021

Nov 09, 2021

BUY
$310.19 - $376.2 $48,699 - $59,063
157 Added 4.19%
3,901 $1.27 Million
Q2 2021

Aug 11, 2021

SELL
$262.71 - $351.17 $4,728 - $6,321
-18 Reduced 0.48%
3,744 $1.17 Million
Q1 2021

May 12, 2021

BUY
$285.92 - $355.13 $17,727 - $22,018
62 Added 1.68%
3,762 $1.2 Million
Q4 2020

Feb 12, 2021

SELL
$251.88 - $324.2 $20,150 - $25,936
-80 Reduced 2.12%
3,700 $1.2 Million
Q3 2020

Nov 12, 2020

BUY
$255.22 - $317.0 $13,016 - $16,167
51 Added 1.37%
3,780 $1.05 Million
Q2 2020

Aug 12, 2020

SELL
$141.4 - $257.09 $7,070 - $12,854
-50 Reduced 1.32%
3,729 $901,000
Q1 2020

May 13, 2020

SELL
$130.51 - $196.01 $287,252 - $431,418
-2,201 Reduced 36.81%
3,779 $549,000
Q4 2019

Feb 12, 2020

SELL
$159.31 - $223.54 $86,346 - $121,158
-542 Reduced 8.31%
5,980 $1.02 Million
Q3 2019

Nov 12, 2019

BUY
$175.89 - $279.23 $30,077 - $47,748
171 Added 2.69%
6,522 $1.16 Million
Q2 2019

Aug 09, 2019

SELL
$250.96 - $284.94 $545,336 - $619,174
-2,173 Reduced 25.49%
6,351 $1.65 Million
Q1 2019

May 10, 2019

BUY
$276.39 - $362.25 $86,786 - $113,746
314 Added 3.82%
8,524 $2.43 Million
Q4 2018

Feb 08, 2019

BUY
$281.08 - $444.25 $685,554 - $1.08 Million
2,439 Added 42.26%
8,210 $2.67 Million
Q3 2018

Nov 08, 2018

BUY
$354.53 - $449.75 $348,857 - $442,554
984 Added 20.56%
5,771 $2.6 Million
Q2 2018

Aug 10, 2018

BUY
$278.07 - $446.21 $1.33 Million - $2.14 Million
4,787 New
4,787 $1.96 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Norinchukin Bank, The Portfolio

Follow Norinchukin Bank, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.